Patent ID: 7838234

Claim:
A method for classifying a cancer in a patient, comprising comparing the expression levels of each gene in a set of biomarker genes that are expressed in cancerous cells to a first set or second set of previously established threshold values for each gene in the set of biomarker genes, and indicating that the cancer is sensitive to a HDAC inhibitor if the expression levels of each gene in the set of biomarker genes are lower than the first set of threshold values for each gene in the set of biomarker genes, or indicating that the cancer is resistant to a HDAC inhibitor if the expression levels of each gene in the set of biomarker genes is greater than the second set of threshold values for each gene in the set of biomarker genes, wherein the set of biomarker genes comprises DEFA6, ITGB4, TM4SF3, SYK, PPAP2C, RAB25, and IL18.